Cabaletta Bio, Inc. (CABA) Tops Q4 EPS by 6c

Cabaletta Bio, Inc. (NASDAQ: CABA) reported Q4 EPS of ($0.40), $0.06 better than the analyst estimate of ($0.46).

For earnings history and earnings-related data on Cabaletta Bio, Inc. (CABA) click here.

You May Also Be Interested In

• Benchmark initiates Synopsys, Cadence with Buy ratings on AI-driven EDA outlook
• Ligand Pharma (LGND) PT Raised to $335 at Benchmark as XOMA Royalty Cash Acquisition Completed
• Abbott beats second-quarter estimates, raises 2026 guidance